Bibliography
Can research at the end of life be a useful tool to advance HIV cure?. AIDS. 2017 ;31(1):1-4.
. Plasma (1 → 3)-β-D-glucan and suPAR levels correlate with neurocognitive performance in people living with HIV on antiretroviral therapy: a CHARTER analysis. J Neurovirol. 2019 ;25(6):837-843.
Heme oxygenase-1 deficiency accompanies neuropathogenesis of HIV-associated neurocognitive disorders. J Clin Invest. 2014 ;124(10):4459-72.
. Heme oxygenase-1 promoter region (GT)n polymorphism associates with increased neuroimmune activation and risk for encephalitis in HIV infection. J Neuroinflammation. 2018 ;15(1):70.
. Expression profiling suggests microglial impairment in human immunodeficiency virus neuropathogenesis. Ann Neurol. 2018 ;83(2):406-417.
. Psychiatric implications of hepatitis-C infection. Crit Rev Neurobiol. [Internet]. 2007 ;19:79-118. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19409058
. Progressive cerebral injury in the setting of chronic HIV infection and antiretroviral therapy. Journal of NeuroVirology [Internet]. 2013 ;19(3):209-218. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23613008
. White matter tract injury and cognitive impairment in human immunodeficiency virus-infected individuals. J Neurovirol. 2009 ;15(2):187-95.
Computerized reaction time battery versus a traditional neuropsychological battery: detecting HIV-related impairments. Journal of the International Neuropsychological Society: JINS [Internet]. 2003 ;9(1):64-71. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12570359
Neuronal accumulation of hyperphosphorylated tau protein predicts stable memory impairment in people living with HIV. AIDS. 2023 ;37(8):1247-1256.
. Inflammatory pseudotumor associated with HIV, JCV, and immune reconstitution syndrome. Neurology [Internet]. 2009 ;72:289-290. Available from: http://www.ncbi.nlm.nih.gov/pubmed/19153378
. HIV-associated Antiretroviral-Associated Neuropathy: Impact of Race and Ethnicity in a Prospective Cohort Study. In: Integrated Neuroscience platform presentation. Vol. 68. 12th ed. Integrated Neuroscience platform presentation. ; 2006. p. Suppl 1, A408.
. Identification of a serotonin/glutamate receptor complex implicated in psychosis. Nature [Internet]. 2008 ;452:93-7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18297054
Identification of Emerging Macrophage-Tropic HIV-1 R5 Variants in Brain Tissue of AIDS Patients without Severe Neurological Complications. J Virol. 2017 ;91(20).
. Independent evolution of macrophage-tropism and increased charge between HIV-1 R5 envelopes present in brain and immune tissue. Retrovirology [Internet]. 2012 ;9:20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22420378
. A role for semaphorin 3A signaling in the degeneration of hippocampal neurons during Alzheimer's disease. Journal of Neurochemistry [Internet]. 2004 ;91(3):716-36. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15485501
. Older age and plasma viral load in HIV-1 infection. AIDS. 2004 ;18 Suppl 1:S87-98.
Cerebrospinal and peripheral human immunodeficiency virus type 1 load in a multisite, randomized, double-blind, placebo-controlled trial of D-Ala1-peptide T-amide for HIV-1-associated cognitive-motor impairment. Journal of NeuroVirology [Internet]. 2006 ;12(3):178-89. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16877299
Deficient Emotion Processing is Associated with Everyday Functioning Capacity in HIV-associated Neurocognitive Disorder. Arch Clin Neuropsychol. 2018 ;33(2):184-193.
. Asymptomatic HIV-associated neurocognitive impairment increases risk for symptomatic decline. Neurology. 2014 ;82(23):2055-62.
National NeuroAIDS Tissue Network (NNTC). In: International AIDS Conference. International AIDS Conference. Bangkok, Thailand; 2004.
. The National NeuroAIDS Tissue Consortium: A new resource to support studies on neuropathogenesis for HIV. In: Journal of NeuroVirology. Vol. 6. Journal of NeuroVirology. ; 2000. p. 244.
. National NeuroAIDS Tissue Consortium [NNTC]. In: Journal of NeuroVirology. Vol. 9. S3th ed. Journal of NeuroVirology. ; 2003. p. 113.
. Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS (London, England) [Internet]. 2005 ;19(4):407-11. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15750394
.